University of Michigan

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).

1,327 total trials 179 currently recruiting 971 completed early-phase tilt top decile by trial count

University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.

University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.

Top-decile sponsor footprint

University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,327 total, page 17 of 27

COMPLETED NA

Exercise Induced Changes in Fat Metabolism

NCT02581306

COMPLETED Phase 2

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

NCT02654977

COMPLETED NA

ABC Brain Games Self-Regulation Intervention

NCT03060863

COMPLETED

Accuracy of Electronic Apex Locators ProMark, RootZX II and NRG Rider on Working Length of Multi-rooted Teeth

NCT02521909

COMPLETED NA

Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer

NCT02564835

COMPLETED NA

Peer Mentorship to Reduce Suicide Risk Following Psychiatric Hospitalization

NCT02365116

COMPLETED NA

A Mind-body Intervention to Improve Body and/or Self Image

NCT02531997

TERMINATED Phase 3

Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

NCT02518971

COMPLETED Phase 4

Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5

NCT02392208

COMPLETED

REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE

NCT01369407

COMPLETED NA

Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders

NCT02439762

COMPLETED

Automated Measurement of Optic Nerve Sheath Diameter

NCT02786706

TERMINATED Phase 4

Double-Blind Placebo-Controlled CIN Trial

NCT02467075

COMPLETED NA

Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

NCT02495155

COMPLETED

Conventional and Metabolomic Predictors of Prediabetes & Insulin Resistance

NCT05055219

COMPLETED NA

The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression

NCT02769858

COMPLETED

The Lung Microbiome in Sarcoidosis

NCT02520323

COMPLETED NA

Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room

NCT02915068

COMPLETED NA

A Brief MI Intervention in the ED to Increase Child Passenger Restraint Use

NCT02496481

COMPLETED

Carbon-11 Labeled Sarcosine in Prostate Cancer

NCT02462447

COMPLETED NA

The Positive Piggy Bank - A Positive Activities Intervention for Improving Functional Status in Patients With Back Pain

NCT02476812

COMPLETED NA

Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages

NCT02454660

COMPLETED NA

Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion

NCT02455037

COMPLETED Phase 2

Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears

NCT02420353

COMPLETED Early Phase 1

Non Invasive Brain Stimulation for PTSD

NCT02442843

COMPLETED NA

An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia

NCT02420535

COMPLETED Phase 2

Dimethyl Fumarate for Obstructive Sleep Apnea

NCT02438137

COMPLETED

Effectiveness of Video Messaging About Diet, Exercise and Weight Gain in Pregnancy in Regional and National Samples

NCT02490579

COMPLETED NA

Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

NCT02444195

COMPLETED NA

Sleep to Activate Mood Promotion

NCT02413294

COMPLETED NA

Psychotherapeutic Text Messaging for Depression Pilot Study

NCT02872454

COMPLETED NA

MiSSION STRONG - Preventing AOS Misuse in the National Guard

NCT02181283

TERMINATED Phase 4

Trial of High Dose Vitamin D in Patient's With Crohn's Disease

NCT02208310

COMPLETED NA

Neurocircuit Mechanisms of OCD Across the Lifespan

NCT02437773

COMPLETED Early Phase 1

Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines

NCT02385877

COMPLETED NA

Test of Hearing Health Education Programs for Farm and Rural Youth

NCT02472821

COMPLETED NA

Clinical Trial of a Serious Game for Individuals With SCI/D

NCT02341950

TERMINATED NA

University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project

NCT02344342

TERMINATED Phase 3

Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth Abrasion

NCT02519738

COMPLETED

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease

NCT02458430

COMPLETED NA

Prevention of Substance Use in Youth in Ukraine

NCT02347644

COMPLETED NA

Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment

NCT02806869

COMPLETED NA

Serotonin and Amyloidopathy

NCT02895932

COMPLETED Phase 1

A Novel Intervention Promoting Eating Disorder Treatment Among College Students

NCT02284685

COMPLETED NA

Neuroimaging Approaches to Deconstructing Acupuncture for Chronic Pain

NCT02064296

COMPLETED NA

A Community Partnership to Treat Stroke

NCT01499173

COMPLETED NA

MiVideo - Video Visit Summary for Cancer Patients

NCT02308345

COMPLETED NA

Electronic Bridge to Mental Health for College Students

NCT03380117

COMPLETED NA

Stage 3 Fontan Operation Liver Ultrasound Study

NCT02269709

COMPLETED NA

Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis

NCT02301377

← Previous Page 17 of 27 Next →

Phase Distribution

PhaseTrial count
Phase 1 79
Phase 2 80
Phase 3 25
Phase 4 69

What is open in the University of Michigan pipeline

179 recruiting of 1,327 indexed (13% open); 971 completed (73%).

Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).

Top condition: Depression (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Michigan: open-pipeline peers nationwide

Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share University of MichiganEli Lilly and CompanyGlaxoSmithKlineAstraZenecaUniversity of Colorado, DenverWayne State UniversityCase Comprehensive Cancer CenterAlbany Medical CollegeTaiho Oncology
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,327 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Michigan page

1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.

  • 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.